跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe
Approved
STANDARD
FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe
Ferring Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a913bb62dcb2ebfe
Company
Ferring Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
a913bb62dcb2ebfe
Product Name
FIRMAGON degarelix (as acetate) composite 120 mg powder in vial and solvent for injection in pre-filled syringe
Artg Id
200046
Artg Name
FIRMAGON degarelix (as acetate) composite pack120mg powder in vial and solvent for injection in pre-filled syringe
Sponsor
Ferring Pharmaceuticals Pty Ltd
Company Detail Path
/organization/ferring-pharmaceuticals-inc
Artg Date
2012-10-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-06865-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06864-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a913bb62dcb2ebfe
Type
Standard
Back to TGA Approvals